Mayuvachi Pharmaceuticals Private Limited
About Mayuvachi Pharmaceuticals Private Limited
Data last updated:
Mayuvachi Pharmaceuticals Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 16 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2016PTC035555. Its GSTIN is 23AAKCM2458F1ZK (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vaibhav Dixit and Jitendra Prajapati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at W – 3/59 Transport Nagar, Gwalior, Madhya Pradesh, India – 474001.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.6 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹35,630 (net margin 2%) and EBITDA of ₹50,340 (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mayuvachi Pharmaceuticals Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressW – 3/59 Transport Nagar, Gwalior, Madhya Pradesh, India – 474001
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mayuvachi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
Financials of Mayuvachi Pharmaceuticals Private Limited
FY 2025 filings availableMayuvachi Pharmaceuticals Private Limited reported revenue of ₹17.6 Lakh (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 24% growth in the latest year. EBITDA rose 199% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹50,340 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35,630 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mayuvachi Pharmaceuticals Private Limited
Mayuvachi Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaibhav Dixit | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
| Jitendra Prajapati | Director | 16 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Mayuvachi Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pacur Pharmaceuticals Private Limited | ₹17.66 Lakh (FY 2024) | 44.0% | Chhindwara, Madhya Pradesh, India | |||
| Mayuvachi Pharmaceuticals Private Limitedthis company | ₹17.6 Lakh (FY 2025) | ₹35,630 | 2% | 24.0% | Gwalior, Madhya Pradesh, India | |
| Victomed Pharmaceuticals Private Limited | ₹17.58 Lakh (FY 2025) | -2.0% | Theni, Tamil Nadu, India | |||
| Bioscodex Pharmaceuticals Private Limited | ₹17.57 Lakh (FY 2019) | 93.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
Auditor
Mayuvachi Pharmaceuticals Private Limited is audited by RAJESHRAMESH&CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJESHRAMESH&CO. | FY 2017 | 012497C |
Shareholding
The shareholding of Mayuvachi Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mayuvachi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mayuvachi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mayuvachi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAKCM2458F1ZK | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mayuvachi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mayuvachi Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Jitendra Prajapati was appointed as Director on 16 Mar 2016.
Frequently asked questions
Mayuvachi Pharmaceuticals is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 16 March 2016 (10+ years old) and is registered under CIN U24230MP2016PTC035555.
Mayuvachi Pharmaceuticals has 2 current directors:
- Vaibhav Dixit - Director
- Jitendra Prajapati - Director
The latest financial statements of Mayuvachi Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Mayuvachi Pharmaceuticals is 23AAKCM2458F1ZK, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Mayuvachi Pharmaceuticals is U24230MP2016PTC035555. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mayuvachi Pharmaceuticals was incorporated on 16 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Mayuvachi Pharmaceuticals by revenue are Pacur Pharmaceuticals Private Limited, Victomed Pharmaceuticals Private Limited, Bioscodex Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jitendra Prajapati was appointed as Director on 16 Mar 2016. Vaibhav Dixit was appointed as Director on 16 Mar 2016.
The registered office of Mayuvachi Pharmaceuticals is at W – 359 Transport Nagar, Gwalior, Madhya Pradesh, India – 474001.
Mayuvachi Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.
The compliance status of Mayuvachi Pharmaceuticals is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.